Transplantation

Article	Citations
236.8: Early Surgical Complications in Everolimus (EVR) Treated Renal Transplant Recipients	166
332.10: Pre-transplant Coronary Angiography Findings Based on Coronary or Aorto-Iliac Calcification on CT Imaging in Asymptomatic Patients With a Negative Cardiac Stress Test	161
426.5: Regular Physical Activity in the Prevention of Post-transplant Diabetes Mellitus and Associated Metabolic Conditions in Kidney Transplant Recipients	153
216.14: Validating a Cut-off of IgG Hypogammaglobulinemia as a Risk Factor of Severe Infection in Solid Organ Transplantation	93
P8.112: Pregnancy Outcomes in Kidney Transplant Recipients And Their Newborns	88
425.4: The Role of Role of Sex and T Cells in Natural vs Induced ABO Antibody Production in Mice	88
P9.35: Application of CRL-Classification (J. Yan ET AL., 2020) Principles for Description of Rare Hepatic Artery Anomalies	69
247.9: Liver Transplantation from Discarded Liver Grafts. A Useful Policy for Expanding the Liver Donor Pool in Mexico	65
240.7: Macrophages and Different Subtypes Infiltrated in Kidney Allografts With Antibody-Mediated Rejection	63
310.8: OVID-Related Neonatal Cholestasis? Liver Transplantation in Three Infants With Perinatal COVID Exposure	57
210.10: Seroconversion After Vaccination With BNT162b2 Pfizer/BioNTech, ChAdOx1 nCoV-19/AZD1222 and Coronavac Against Sars-cov-2 Among Hemodialysis and Kidney Transplant Patients	53
414.3: Review of the Safety and Efficacy of Immunosuppression in the Pig-To-Nonhuman Primate Islet Xenotransplantation Model	52
410.5: The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study	50
P2.11: Distinct Global DNA Methylation and NF-κB Expression Profile of Preimplantation Biopsies From Ideal and Non-ideal Kidneys	50
313.5: Meeting Packed Red Blood Cell Requirement for the Transmedics Organ Care System (OCS) Liver Transplantation Trial (PROTECT Trial) At Henry Ford Hospital	48
340.11: Flow Cytometric Pattern of Gamma Delta TCR Expression Identifies Outcomes in Kidney Transplantation	46
P8.067: Catastrophic EBV Infection After Cadaveric Kidney Transplantation	44
P8.142: Perturbations in Podocyte Transcriptome and Biological Pathways Induced by Injury Caused by FSGS Associated Circulating Factors	42
P10.03: Alternative Surgical Techniques for Abdominal Wall Graft Donation to Guarantee Abdominal Wall Closure in the Donor	41
P11.38: Impact of Two Different TV Content on Promote Organ Donor Registration	40
316.7: ABO – Incompatible Kidney Transplantation in COVID 19 Era: A Single Centre Experience	38
P5.01: Belt & Road Organ Donation Capacity Improvement Cooperation Training Project (BROAOD)	38
P17.07: Comparison of Graft Survival Between Full Thickness And Lamellar Pig-To-Monkey Corneal Xenotransplantation From the Same Genetically Engineered Pig With Minimal Immunosuppression	38
P8.027: Idiopathic Polymyositis in Renal Transplant Recipient: Case Report and Review of Literature	37
414.10: Cytokine Analysis of First Gal-KO Renal Xenotransplantation From a Pig-To-Human Recipient	37

P9.40: Liver Transplantation for Secondary Hemophagocytic Lymphohistiocytosis Associated Acute Liver Failure: A Case Report	36
P11.30: Influence of Basic Cardiopulmonary Reanimation on Uncontrolled Donors After Cardiac Death	35
364.1: Survival benefit of living donor availability for pediatric liver transplantation in a large North American center: An intention-to-treat analysis.	34
313.2: Solitary Pancreas Transplantation - Significant Improvement over the 2 last Decades	33
313.1: A novel risk factor for immediate pancreas graft failure: hypertension in the donor	33
245.8: Effect of CYP3A5 Genotype-Guided Versus Conventional Initial Dose of Tacrolimus in Children With Kidney Transplants	33
ILTS 2022 Joint International Congress of ILTS, ELITA & LICAGE, May 4-7, 2022	33
217.6: Beneficial effects of transgenic expression of human CD200 on top of quadruple-knockout/double-knockin (CD46/thrombomodulin) pigs on kidney xenograft survival in nonhuman primates	32
328.2: A bioengineered artificial interstitium supports long-term survival of therapeutic xenogeneic porcine islet cells in nonhuman primates without immunosuppression	32
236.3: Improved outcomes following simultaneous pancreas-kidney transplantation in the second decade of the new millennium: a single center longitudinal analysis by era	31
236.4: Early differences in glucose homeostasis between diabetes type 1 versus type 2 recipients of kidney/pancreas transplants	31
237.2: Synergistic inhibition of human NK cell activation by co-expression of HLA-E and HLA-G on porcine endothelial cells	31
P.13: Effect of human amniotic epithelial cells on intraportal islet transplantation	31
P.333: Interferon-gamma release test results in organ transplant recipients and donors at Başkent University Faculty of Medicine Hospital.	31
P.425: Kidney donation and kidney transplantation among Ukrainians in Poland within two years of war in Ukraine.	30
P4.5: Red cell distribution width (RDW): A prognosis indicator of brain death in patients with GCS<6	30
P.345: Biliary sludge and complications in multivisceral transplantation patients.	30
366.1: iRhom2 regulates hepatocyte senescence in ischemia/reperfusion injury by modulating HMGB1 secretion.	30
P8.6: A historical review of heart transplantation in Saudi Arabia: trends, progress, and heart valve utilization	29
123.7: How to increase organ and tissue donation with a low budget and better approach	28
P.370: Correction of portal vein stenosis in patients following living donor liver transplantation.	27
P1.1: Laryngotracheal transplant: Patient and caregivers’ beliefs and perceptions	27
403.3: Beyond kidney donation: Unveiling predictors of long-term kidney function in living donors.	27
116.5: Empowering organ donation advocates through online grass-root level volunteer training: ‘the organ donation ambassadors program’	27
P.506: Outcome of heart transplant in a young patient referred with cardiogenic shock and multi-organ failure.	27
P.303: An exploratory study of patient-provider communication during the medical evaluation for kidney transplantation.	26
P.488: Pediatric liver transplantation in Situs inversus and other vascular abnormalities.	26
322.4: Engineering pancreatic islet grafts with innate immune modulators to mitigate instant blood-mediated inflammatory reaction.	26
P.493: Utilization of mechanical assist devices in pediatric patients with end-stage heart failure.	26
320.12: The outcomes of renal transplantation in congenital chloride diarrhea- A cases series.	26
P.086: Endoplasmic reticulum stress in recipient spleen follicular B lymphocytes in transplantation may affect the alloimmune response of T lymphoctes.	25
247.11: Comparative assessment of steatotic livers in preservation solutions: New compositions for old problems.	25
300.4: First experience of extracorporeal-cardiopulmonary resuscitation program and its impact in kidney transplant.	25
264.9: GSK3β deficiency ameliorates hepatic ischemia-reperfusion injury by regulating necroptosis of kupffer cells.	25
V-210.3: Paired kidney exchange program: A utilitarian service to the underserved populations in the northern great plains of the United States.	25
247.5: Mitochondrial flavin mononucleotide measured at beginning of hypothermic machine perfusion predicts patient survival after liver transplantation.	25
410.3: Anti-MICA antibodies and graft outcomes in kidney transplant recipients.	25
P.197: Patient’s death with a functioning graft (DWF) from infection is a major cause of renal transplant loss – A retrospective study from a single center.	25
P.044: Rhabdomyolysis after cooked local fish consumption (Haff Disease) in kidney transplant in South of Brazil - Case report.	25
440.2: Clinical study of the importance of IgG level in kidney transplant recipient.	25
410.4: A prospective observational study to assess the role of donor derived cell free DNA (dd-cfDNA) in predicting active rejection in renal allograft recipients.	25
From 6-wk Lungs to 6 y: Increasing the Donor Pool for Pediatric Lung Transplantation	24
P.240: Advanced chronic kidney disease in kidney transplant recipients: A national cross-sectional cohort study.	24
405.2: Kidney transplantation in patients with intellectual disability.	24
Bile Chemistry During Ex Situ Normothermic Liver Perfusion Does Not Always Predict Cholangiopathy	24
323.5: The value of anonymous contact.	24
CXCR5+CD8+ T Cell–mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition	24
107.1: Digital solutions and collaboration between authority and healthcare professions – The winning key to develop and implement guidelines at a national level?	24
308.5: IDEA: Development of the first decisional support tool for black American potential living kidney donors contemplating APOL1 genetic testing.	23
Response to Letter: Global Immune Biomarkers and Donor Serostatus Can Predict Cytomegalovirus Infection Within Seropositive Lung Transplant Recipients	23

Research Highlights	23
Progress Update on the Transplant Surgery Training Pipeline in the United States	23
Patient and Provider Gender and Kidney Transplant Referral in Canada: A Survey of Canadian Healthcare Providers	23
New Allocation Systems: Principles and Processes (Pro)	23
216.7: Uniquely Tasmanian – Learnings from our island state.	23
Prediction and Management of Small-for-size Syndrome in Living Donor Liver Transplantation: Methodology of the ILTS-iLDLT-LTSI Consensus Conference	23
Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of Comorbidities and Vaccination	23
Alloreactive Tissue-resident Memory T Cells in Solid Organ Transplantation: Do They Light the Fire?	23
What Can the Developing World (and Others) Learn From the Indian Experience in Crossing the ABO Blood Group Barrier in Kidney Transplantation	22
Renal Transplantation in the Dominican Republic: Achievements, Challenges, and Gender Disparities	22
14-4: INVESTIGATING THE SUBCUTANEOUS SPACE AS AN ALTERNATIVE TRANSPLANT SITE FOR ISLET TRANSPLANTATION	22
Never Say Never: The Latest Immune Rejection Ever Reported 51 y After Corneal Transplantation	22
Research Highlights	22
06-8: ISOLATION, CHARACTERIZATION AND DISTRIBUTION OF HUMAN PANCREATIC ISLETS FOR RESEARCH	22
01-8: HEPARIN THROMBOPROPHYLAXIS AFTER PANCREAS TRANSPLANTATION IMPROVES OUTCOMES: A SINGLE-CENTER EXPERIENCE	22
Donor-derived Cell-free DNA and Acute Kidney Rejection: A Golden Opportunity or a False Hope?	22
P-16: USING A TRANSIENT COLD ROOM DURING COBE ISLET PURIFICATION REDUCES THE ENVIRONMENTAL MICROBIAL BURDEN AND ASSOCIATED ENERGY COSTS WHEN COMPARED TO THE USE OF A PERMANENT COLD ROOM	22
337.5: Islet transplantation versus insulin alone in type 1 diabetic kidney transplant recipients: a French nationwide study on behalf of the TREPID group	21
Research Highlights	21
47: 10 Years’ Experience of Transplant Oncology in the Management of Unresectable Desmoid Tumor: One-staged or Two-staged Approach	21
18. Lessons learned in sentinel skin flap vascularised composite allotransplantation through patient and public involvement	21
Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study	21
PS13.5: First-in-human trial of the treatment with human embryonic stem (ES) cell-derived hepatocyte-like cells for infantile urea cycle disorders.	21
The Challenges of Risk Aversion in Kidney Transplantation: Lessons From the SARS-CoV-2 Pandemic in Brazil	21
P3.05: Apraglutide Decreases Severity of Intestinal Damage From Acute Gastrointestinal Graft Versus Host Disease (GI-GvHD) Following Allogeneic Transplantation Without Impacting Engraftment	21
Dynamics of Humoral and Cellular Responses in Renal Transplant Recipients Receiving 3 Doses of SARS-CoV-2 mRNA Vaccine	20
Highlights From Controversies in Transplantation 2023 Conference	20
Unraveling Molecular and Functional Responses Across 3 Lung Injury Models to Expand the Donor Lung Pool	20
Research Highlights	20
Senotherapy: Implications for Transplantation	20
Deceased Donor Liver Procurement and Preservation Techniques: What is Cost-effective? A Systematic Review	20
Using Regression Equations to Enhance Interpretation of Histology Lesions of Kidney Transplant Rejection	20
Rethinking Priority for Prodonation Behaviors in Organ Allocation—Lessons From the Israeli Experience	20
IL-35 Therapy Boosts Treg in Transplantation	20
416.5: Pregnancy-Induced Sensitization in Female Transplant Candidates: HLA-Specific Memory B Cells and Paternal HLA Epitope Mismatch	20
Back to Basics: Liver Graft Ischemia in the Era of Machine Perfusion	19
Amplified Natural Killer Cell Activity and Attenuated Regulatory T-cell Function Are Determinants for Corneal Alloimmunity in Very Young Mice	19
WTC 2025 Highlights: Infectious Disease	19
Outcomes of Coccidioides Seropositive Solid Organ Transplant Recipients After Self-discontinuation of Antifungal Prophylaxis: The EIA-IgM-only Conundrum	19
Global Disparities in Liver Transplantation Relative to the Burden of Cirrhosis and Other Chronic Liver Diseases (2000–2023)	19
Research Highlights	19
Circulating Mitochondrial Transfer Carrying Dihydroorotate Dehydrogenase Reduces Oxidative Cell Death in Prolonged Cold-induced Cardiac Reperfusion Injury in Heart Transplantation	19
Prognostic Value of Chest CT Findings at BOS Diagnosis in Lung Transplant Recipients	19
Insight Into Current BK Polyomavirus Research Efforts: BK Day Meeting 2024	19
Response to: Early Refusal Pattern Phenotyping as a Surrogate for Organ Quality Assessment in Kidney Allocation	19
P12.15: Dapagliflozin for the Treatment of Post-transplant Diabetes Mellitus After Pancreas Transplantation: A Case Report With A 14-Month Follow-up	18
Chronic Rejection After Kidney Transplantation	18
Can We Use Eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The Hope and the Hype	18
Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection	18
Liver Retransplantation Using Living Donor Grafts: A Feasible Approach for Chronic Allograft Failure	18
32: 30-year experience of children with Intestinal Failure Associated liver disease	18
Cold Storage Disrupts the Proteome and Phosphoproteome Landscape in Rat Kidney Transplants	18
Psychometric Properties of the BAASIS: A Meta-analysis of Individual Participant Data	18
Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation	18
Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death	18
Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular	18
Dysbiosis of the Female Murine Gut Microbiome Exacerbates Neutrophil-mediated Vascular Allograft Injury by Affecting Immunoregulation by Acetate	17
Hepato–Cardio–Renal Interactions and Transplant Implications	17
113: Complications of vascular Ehlers-Danlos Syndrome: Management by an Intestinal Failure Multidisciplinary Team	17
261.13: The setup used for ex vivo renal normothermic perfusion influences a kidney’s behavior on the pump.	17
Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms	17
People in Transplantation: John Fung, MD, PhD, President of The Transplantation Society	17
261.12: Novel system for organ preservation: Feed macrophages Ceria nanoparticles.	17
16: RNA Sequencing (RNA-seq) Analysis Provides for Gene Signatures Specific to Intestinal Transplant Rejection	17
Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance	17
Declining All-cause Allograft Survival in the Modern era: A 50-y Single-center Consecutive Cohort Study	17
264.4: Macrophage SETDB1 reduces inflammatory macrophage infiltration by inhibiting P2rx7 expression and alleviates liver ischemia-reperfusion injury.	17
P.077: Engineered mesenchymal stem cell-mediated release of the chemokine CCL28 remodels the immune microenvironment to resist graft rejection.	16
P.357: The effects of early postoperative thrombocytopenia at intensive care unit admission to allograft function and outcomes after liver transplantation.	16
P.041: Switching from ciclosporin to tacrolimus as de novo calcineurin inhibitor in lung transplantation: First results of a multidisciplinary quality assurance project.	16
P.100: Are transfusion reactions associated with hematopoietic stem cell product infusion more frequent than previously thought?	16
P.464: Social and structural disparity in possible organ donor discards in Chile.	16
320.15: Recurrence of focal segmental glomerulosclerosis among kidney transplant recipients: Kuwait experience.	16
P.175: Correlation of early graft dysfunction and baseline doppler ultrasound result.	16
245.8: Shiraz Transplant Center; leader of the intestinal transplant in the Middle East; challenges and opportunities.	16
343.3: Up-regulated LRRN2 expression is effective as a marker for graft quality in living donor liver transplantation.	15
P15.10: The Impact of Different Induction Immunosuppression Protocol on Patient Survival, Graft Survival and Acute Graft Rejection After Kidney Transplantation – Multicenter Study	15
421.5: Extracorporeal Membrane Oxygenation Use in Orthotopic Liver Transplantation as a Viable Bridge to Transplant and Tool For Intraoperative and Postoperative Rescue	15
P8.099: Post-operative Myocardial Infarction After Renal Transplant: Setback or Disaster?	15
P8.020: Incidence and Correlates of Testicular Pain After Kidney Donation	15

P.178: Immunologic risk stratification of kidney transplant recipients by combining HLA-eplet MM and PIRCHE-II.	15
317.9: Report of a Case of Double Arm Transplantation Including Left Shoulder Reconstruction	15
P3.02: Assessment of Chimerism Testing by Next Generation Sequencing	15
344.7: Predictive analysis of new-onset diabetes after kidney transplantation: Integrating clinical and radiological factors at Mayo Clinic.	15
241.9: Evaluation of renal allograft biopsy results and long-term allograft survival in kidney transplant recipients: Baskent University experience.	15
P12.11: Immunomodulatory Microporous Annealed Particle (MAP) Gel Protects Delivery of Islets to Promote Islet Transplantation Outcomes	15
P8.135: Machine Learning in Kidney Transplantation: A New Possibility For the Graft Survival Prediction	15
235.2: Prediction of Acute Rejection Post-kidney Transplant: An Artificial Intelligence Approach	14
412.3: The Performance of the Kidney Donor Profile Index in Predicting Outcomes for Brazilian Kidney Transplant Recipients of Standard Criteria Donors	14
242.7: Influence of CYP3A5 Polymorphisms on Tacrolimus Dosing in Renal Transplant Recipients	14
P9.10: Mono-Maintenance Therapy With Anti-icam-1 Monoclonal Antibody Induced Long-term Liver Allograft Survival in Nonhuman Primates	14
210.12: Booster Shots and Additional Doses for COVID-19 in Solid Organ Recipients	14
106.5: Comparison of open surgery and ultrasound-guided percutaneous injection on the cytokine response to pig islet xenotransplantation	14
312.1: Implementation of Longitudinal Portoplasty for Hypoplasic Portal Veins in Children With Biliary Atresia in a Liver Transplantation Centre in Argentina	14
P14.07: Use of Grafts With Extended Ischemic Time (Above 4 Hours Or More): Analysis of the Experience of the Largest Brazilian Heart Transplant Center, From 2013 to 2022	14
400.1: The “Global Kidney Exchange” Proposal Is Impractical And Not Financially Neutral	14
P8.086: Persistent Hyperparathyroidism Post Renal Transplantation	14
216.4: Wide Spectrum of Molecular Injury Highlights Heterogeneity of Banff Tubulitis and Interstitial Inflammation Lesions	14
P8.052: Long-term Outcomes and Predictors of Graft Function in Living-Donor Preemptive Kidney Transplants	14
334.3: Presentation of FasL Protein by PEG Microgels Within Graft Site Leads to Survival of Pancreatic Islets in Nonhuman Primates Without the Need for Chronic Immunosuppression	14
247.6: Preliminary Results of Ex-vivo Normothermic Machine Perfusion in Deceased Donor Renal Allograft Transplantation – First Clinical Experience From Asia	14
246.8: In Vivo Monitoring of Liver Organoids Differentiation Using Live-Screening-Optical Technologies	14
213.4: Single-dose Rituximab Induction May Prevent EBV Viremia in Paediatric Kidney Recipients Long-term: An Investigation From the Nordic Paediatric Renal Transplantatioinn Study Group	14
416.1: Impact of HLA-A,B DR and DQ on Deceased Kidney Transplant Outcomes in the Tacrolimus/MMF Era: An Artificial Intelligence Approach	14
241.2: A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation	14
317.1: Personalized Approach to Risk-Stratified Desensitization in Modified Multivisceral Transplantation	14
246.2: Novel Avenue of Allograft Monitoring: Direct Measurement of Donor-Derived Extracellular Vesicles in Human Plasma	14
243.9: Equality and Equity in Transplant for Children	14
211.8: Impact of Sarcopenia Using Anterior Thigh Skeletal Muscle Index on Clinical Outcomes in the Liver Transplant Recipient	14
343.10: A Novel Approach for Pancreas Transplant With Arterial Patch	14
411.5: Autophagy Mediates Liver Functional Recovery From Donation After Circulatory Death Rats With Normothermic Machine Perfusion	14
121.5: The development progress of “the Shanxi Model”: the first independent provincial OPO in China	13
P9.5: Organ donation between personal and cultural beliefs in Saudi Arabia	13
317.1: Perceptions and potential barriers of personnel involved in xenotransplant research	13
237.4: Evaluation of immune reactions in multi-knockout kidneys after perfusion with human blood	13
236.2: Simultaneous kidney-pancreas transplantation improves endothelial dysfunction induced by extracellular vesicles	13
229.7: The role of sex hormones in the intestinal injury after brain death using a surgical menopause model in rats.	13
405.4: Outcomes of kidney transplantation from uncontrolled donation after circulatory death. A retrospective study of Botkin Hospital.	13
211.3: Donor prostate cancer should not be contraindication for donation of kidney	13
120.4: Preventable harm in the Canadian organ donation and transplantation system (semi colon) a descriptive study of missed organ donor identification and referral	13
105.2: Novel subcutaneous islet transplantation method using a bioabsorbable medical device to facilitate the guidance of the highly vascularized transplantation site	13
320.1: Successful use of organs from donors with severe burns.	13
117.6: Can pyelonephritis initiate antibody-mediated rejection (AMR) of a pig xenograft?	13
204.5: Pediatric kidney transplantation in the Middle East: Challenges and solutions.	13
328.5: Islet encapsulation preserves their functionality following transplantation into immunocompetent diabetic animals without immunosuppression	13
122.6: Increasing kidney utilization	13
123.8: Spotlight on relatives of tissue donors - what factors influence the decision-making process?	13
P3.3: Consider the causes of low organ donation in Japan by the GCS3 registry	13
337.4: Islet-alone vs. islet-after-kidney transplantation glycemic outcomes: Report from the Collaborative Islet Transplant Registry	13
336.5: Modifying The Porcine Genome for Xeno-organ Transplantation	13
Invited Response to Letter to the Editor by Callaghan et al, “Following the Flow: Changes in Organ Preservation Methods Require Changes in Our Data Collection”	13
Replacing the Endomyocardial Biopsy: Easier Said Than Done	12
AI-enhanced Information Navigation: Insights From Information Theory in Transplantation Data	12
16-5: SOCIAL DETERMINANTS IMPACT PANCREAS TRANSPLANT LISTING, TIMING AND OUTCOME	12
118.8: Understanding pancreas-machine interactions during preservation: A mathematical approach	12
211.4: D-Amino acids-based estimation of glomerular filtration rate is possible using the same formula in both children and adults.	12
210.6: Nepal: Learning from the decreased organ donation system in the United States of America to save more lives from organ transplantation.	12
Long-term Comparison of Everolimus and Mycophenolate in Tacrolimus-based and Steroid-free Immunosuppressive Regimen	12
Muhammad M. Mohiuddin, MBBS (MD), DSc (Hon)	12
Utility of OPO Procurement Surgeons in Reducing Discards of Marginal Liver Allografts	12
306.5: From hospice to hope: The DCD pathway to life-saving donations.	12
108.1: Optimizing organ donation in medico legal cases a retrospective review from the National Center for Regulating Donation and Transplantation of Human Organs and Tissues in the United Arab Emirat	12
217.4: Clinical risk aversion of potential deceased kidney donors forgone for biovigilance concerns: A data-linkage study.	12
Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver Transplantation	12
228.8: Artificial pancreatic islets produced by 3D bioprinting ink-jet technology with extracellular matrix as an environment for stem-cell derived beta cells.	12
Amelioration of Diabetes and Neuropathy After Pancreas Transplantation: Measurable Differences in Vibration Perception Thresholds Impact Outcomes	12
P.47: Impact of early versus delayed tacrolimus initiation on clinical outcomes in deceased donor kidney transplantation with thymoglobulin induction: Implications for graft allocation.	12
305.1: Non-retrieval and non-utilisation of deceased donor kidneys for transplantation: and Australian cohort study.	12
Mitigating Health Disparities in Transplantation Requires Equity, Not Equality	11
P.56: Intraportal transplantation of amniotic epithelial stem cells in pigs: in vivo kinetics and functional assessment.	11
Preventing Surgical Site Infections After Liver Transplantation: The Optimal Strategy	11
Immune Monitoring Assays: Predicting Cytomegalovirus and Other Infections in Solid Organ Transplant Recipients	11
Desensitization in Crossmatch-positive Kidney Transplant Candidates	11
Automated Computed Tomography–based Liver Steatosis Risk Stratification of Deceased Organ Donors Using Real-world Data	11
Body Size Remains the Major Source of Sex Disparity Despite Updated Liver Transplant Allocation Policies	11
210.6: Development and dissemination of a unique virtual reality training program to improve physician skill, knowledge and confidence in determining brain death and family communication	11
Novel Noninvasive Biomarkers in Liver Transplantation: A Tool on the Doorstep of Clinical Utilization	11
Deceased Organ Donation and Transplantation in the United Arab Emirates: A View 7 y After Implementation	11
344.3: An Inconvenient Offer: A Single OPOs Experience in Kidney Utilization.	11
313.12: Hypothermic Oxygenated Machine Perfusion of an En-Bloc Dual Kidney Specimen: Proof of Concept, in an Animal DCD Model, of a New Option to Preserve and Evaluate Kidney Grafts	11
Molecular Classification Predicts Clinical Outcomes of Kidney Transplant Recipients With Microvascular Inflammation, Donor-specific Antibodies-negative and C4d-negative	11
Inflammation in Kidney Transplantation: Could Xenotransplantation Offer Greater Benefit?	11
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation	11
241.1: Maturation and Evaluation of 3D Printed Bionic Pancreas With a Dedicated Bioreactor	11
Ferroptosis Blockade During Machine Perfusion: A New Lever for Donation After Circulatory Death Heart Transplantation?	11
The Relative Roles of Inflammation in Kidney Allotransplantation and Xenotransplantation	11
Expanding the Therapeutic Horizon of Sodium Glucose Co-transporter-2 Inhibitors in Acute Kidney Injury	11
Orthotopic Liver Transplantation During Pregnancy: The Role of Surgical Technique	11
Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot	11
Incidence of Acute Rejection Compared With Endomyocardial Biopsy Complications for Heart Transplant Patients in the Contemporary Era	11
MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection	11
Clinical Phenotypes in Heart Transplantation: Implications for Prognosis and Personalized Follow-up	11
Pathophysiological Changes in the Hemostatic System and Antithrombotic Management in Kidney Transplant Recipients	11
Tolerability and Effectiveness of Tirzepatide in Kidney Transplant Recipients: Real-world Experience From a Single-center Study	11
ABO Antibody Development, a New Look at a Very Old Question	11